ACRS
Aclaris Therapeutics Inc
NASDAQ: ACRS · HEALTHCARE · BIOTECHNOLOGY
$4.47
+5.92% today
Updated 2026-04-29
Market cap
$624.30M
P/E ratio
—
P/S ratio
79.77x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $5
Volume
2.0M
Aclaris Therapeutics Inc (ACRS) Insider transactions
Net insider activity
Net buying (4,896,847 shares)
Buy transactions
55
Sell transactions
45
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 2,375 | — | — |
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 2,375 | — | — |
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 677 | $2.87 | $1942.99 |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Sale | 63,475 | — | — |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Buy | 63,475 | — | — |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Sale | 18,611 | $3.47 | $64580.17 |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Sale | 20,875 | — | — |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Buy | 20,875 | — | — |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Sale | 5,937 | $3.47 | $20601.39 |
| 2026-02-03 | DAVIS, HUGH M. | Director, President and COO | Sale | 18,675 | — | — |
| 2026-02-03 | DAVIS, HUGH M. | Director, President and COO | Buy | 18,675 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 22,025 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 22,025 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 6,449 | $3.47 | $22378.03 |
| 2026-02-02 | WALKER, NEAL | Director, CEO | Buy | 274,800 | — | — |
| 2026-02-02 | WALKER, NEAL | Director, CEO | Buy | 961,700 | — | — |
| 2026-02-02 | LOEROP, JAMES | Chief Business Officer | Buy | 97,700 | — | — |
| 2026-02-02 | LOEROP, JAMES | Chief Business Officer | Buy | 341,900 | — | — |
| 2026-02-02 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 95,700 | — | — |
| 2026-02-02 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 334,900 | — | — |
| 2026-02-02 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 98,100 | — | — |
| 2026-02-02 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 343,300 | — | — |
| 2026-02-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 96,100 | — | — |
| 2026-02-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 336,300 | — | — |
| 2026-02-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 99,100 | — | — |
| 2026-02-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 346,800 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 14,750 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 11,250 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 7,500 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 14,750 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 11,250 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 10,686 | $3.51 | $37507.86 |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 7,500 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 14,750 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 14,750 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 4,984 | $3.51 | $17493.84 |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Sale | 29,150 | — | — |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Buy | 29,150 | — | — |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Sale | 9,952 | $2.88 | $28661.76 |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Sale | 18,150 | — | — |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Buy | 18,150 | — | — |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Sale | 6,171 | $2.88 | $17772.48 |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 13,200 | — | — |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 13,200 | — | — |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 4,461 | $2.88 | $12847.68 |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 7,500 | — | — |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 7,500 | — | — |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 2,250 | $3.01 | $6772.50 |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Sale | 73,750 | — | — |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Buy | 73,750 | — | — |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Sale | 33,994 | $3.01 | $102321.94 |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 73,750 | — | — |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 73,750 | — | — |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 19,934 | $3.01 | $60001.34 |
| 2025-12-02 | DAVIS, HUGH M. | Director, President and COO | Sale | 26,750 | — | — |
| 2025-12-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 26,750 | — | — |
| 2025-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 145,500 | — | — |
| 2025-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 510,000 | — | — |
| 2025-06-06 | SCHIFF, ANDREW N | Director | Sale | 4,793 | — | — |
| 2025-06-06 | SCHIFF, ANDREW N | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MOLINEAUX, CHRISTOPHER P. | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MILANO, VINCENT | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MILANO, VINCENT | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MEHRA, ANAND | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MEHRA, ANAND | Director | Buy | 4,793 | — | — |
| 2025-06-06 | HUMPHRIES, WILLIAM D. | Director | Sale | 4,793 | — | — |
| 2025-06-06 | HUMPHRIES, WILLIAM D. | Director | Buy | 4,793 | — | — |
| 2025-06-06 | GOWEN, MAXINE | Director | Sale | 4,793 | — | — |
| 2025-06-06 | GOWEN, MAXINE | Director | Buy | 4,793 | — | — |
| 2025-06-05 | SCHIFF, ANDREW N | Director | Buy | 42,350 | — | — |
| 2025-06-05 | SCHIFF, ANDREW N | Director | Buy | 11,580 | — | — |
| 2025-06-05 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 42,350 | — | — |
| 2025-06-05 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 11,580 | — | — |
| 2025-06-05 | MILANO, VINCENT | Director | Buy | 42,350 | — | — |
| 2025-06-05 | MILANO, VINCENT | Director | Buy | 11,580 | — | — |
| 2025-06-05 | MEHRA, ANAND | Director | Buy | 42,350 | — | — |
| 2025-06-05 | MEHRA, ANAND | Director | Buy | 11,580 | — | — |
| 2025-06-05 | HUMPHRIES, WILLIAM D. | Director | Buy | 42,350 | — | — |
| 2025-06-05 | HUMPHRIES, WILLIAM D. | Director | Buy | 11,580 | — | — |
| 2025-06-05 | GOWEN, MAXINE | Director | Buy | 42,350 | — | — |
| 2025-06-05 | GOWEN, MAXINE | Director | Buy | 11,580 | — | — |
| 2025-05-01 | WALKER, NEAL | Director, CEO | Sale | 9,467 | — | — |
| 2025-05-01 | WALKER, NEAL | Director, CEO | Buy | 9,467 | — | — |
| 2025-05-01 | WALKER, NEAL | Director, CEO | Sale | 2,975 | $1.38 | $4105.50 |
| 2025-05-01 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 145,500 | — | — |
| 2025-05-01 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 510,000 | — | — |
| 2025-04-01 | WALKER, NEAL | Director, CEO | Sale | 9,467 | — | — |
| 2025-04-01 | WALKER, NEAL | Director, CEO | Buy | 9,467 | — | — |
| 2025-04-01 | WALKER, NEAL | Director, CEO | Sale | 3,042 | $1.48 | $4502.16 |
| 2025-03-01 | WALKER, NEAL | Director, CEO | Sale | 9,466 | — | — |
| 2025-03-01 | WALKER, NEAL | Director, CEO | Buy | 9,466 | — | — |
| 2025-03-01 | WALKER, NEAL | Director, CEO | Sale | 3,277 | $1.99 | $6521.23 |
| 2025-03-01 | MONAHAN, JOSEPH | Chief Scientific Officer | Sale | 50,000 | — | — |
| 2025-03-01 | MONAHAN, JOSEPH | Chief Scientific Officer | Sale | 10,925 | — | — |
| 2025-03-01 | MONAHAN, JOSEPH | Chief Scientific Officer | Buy | 50,000 | — | — |
| 2025-03-01 | MONAHAN, JOSEPH | Chief Scientific Officer | Sale | 27,258 | $1.99 | $54243.42 |
| 2025-03-01 | MONAHAN, JOSEPH | Chief Scientific Officer | Buy | 10,925 | — | — |
| 2025-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 2,375 | — | — |
| 2025-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 1,100 | — | — |